Article info

Download PDFPDF
Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550 mg/m2 in patients with recurrent ovarian and peritoneal cancer

Authors

  1. Address correspondence and reprint requests to: Yusuf Yildirim, MD, Çalikuşu Mah, 3208 sok, Aksa Apt, No 2, D: 6 35380 Bozyaka, İzmir, Turkey. Email: dr.yusufyildirim{at}yahoo.com.tr

Citation

Yildirim Y, Gultekin E, Avci ME, et al
Cardiac safety profile of pegylated liposomal doxorubicin reaching or exceeding lifetime cumulative doses of 550 mg/m2 in patients with recurrent ovarian and peritoneal cancer

Publication history

  • First published February 1, 2008.
Online issue publication 
February 01, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.